Area of research
Epidemiology · Dermatology
Research interest
Research interests include Medicine, Placebo, Vaccination, Confidence interval, Immunogenicity, and Clinical trial.
Safety profile of the adjuvanted recombinant zoster vaccine: Pooled analysis of two large randomised phase 3 trials
Immune Responses to a Recombinant Glycoprotein E Herpes Zoster Vaccine in Adults Aged 50 Years or Older
Quality of Life Impact of an Adjuvanted Recombinant Zoster Vaccine in Adults Aged 50 Years and Older
Efficacy of the Herpes Zoster Subunit Vaccine in Adults 70 Years of Age or Older
Efficacy, Immunogenicity and Safety of an Investigational Subunit Adjuvanted Herpes Zoster Vaccine in Adults Aged 60 Years and Older: Results From the ZOE-50 and ZOE-70 Efficacy Studies
Quality-of-Life Impact of an Investigational Subunit-Adjuvanted Herpes Zoster Vaccine in Adults ≥50 Years of Age
Efficacy of an Adjuvanted Herpes Zoster Subunit Vaccine in Older Adults